SB 2025 is an appropriations bill that funds the Mississippi State Board of Pharmacy for Fiscal Year 2026. It provides $4,154,101 in special funds to cover the board’s operating expenses for the year beginning July 1, 2025, and ending June 30, 2026. Of that amount, $2,799,541 is designated for personal services, including salaries, wages, fringe benefits, and vacancy funding, with authorization for 21 permanent positions and no time-limited positions.
The bill also adds one new permanent headcount for an Attorney position and sets out detailed spending and personnel controls. It requires compliance with the state variable compensation plan, limits transfers out of personal services funds, restricts salary actions that would exceed appropriations, and directs how vacancy funding may be used. The act further allows the board to escalate up to $500,000 under the Pharmacy Benefit Prompt Pay Act for compliance examinations and regulatory oversight, and it authorizes the board to accept funds from other state agencies for the Prescription Monitoring Program.
In addition to the appropriation itself, the bill includes performance targets for licensure timeliness, complaint resolution, investigations, and prescription monitoring registration. It also requires recordkeeping, budget reporting, and compliance with state fiscal law, while giving preference to the Mississippi Industries for the Blind in certain procurement situations. The act takes effect July 1, 2025.
The bill appears to have broad support in both chambers, passing the Senate 38-8 and the House 97-0. The voting history suggests general agreement on funding the board’s core regulatory functions and staffing needs. No committee transcript is available, so there is no recorded debate to indicate additional concerns or amendments.
The main points of potential contention are the size and structure of the appropriation, the addition of a new attorney position, and the board’s authority to escalate funds for pharmacy benefit prompt-pay enforcement. However, the available record does not show active opposition beyond the Senate no votes, and the House vote was unanimous.
SB 2025 updates Mississippi’s fiscal authority for the State Board of Pharmacy by appropriating special funds for FY 2026 and setting binding conditions on how those funds may be spent. It affects state budget law, personnel administration, and pharmacy regulation by establishing the board’s operating budget, authorizing one additional attorney position, limiting salary and vacancy-fund use, and permitting limited budget escalation for prompt-pay compliance work. It also reinforces reporting and accounting requirements and ties the board’s operations to existing statutes governing compensation, procurement, and the Prescription Monitoring Program.
Overall sentiment around the bill was favorable. The measure passed both chambers comfortably, with unanimous support in the House and a strong majority in the Senate, indicating broad legislative agreement that the Board of Pharmacy should be funded at the proposed level. The absence of committee transcripts limits insight into detailed debate, but the vote totals suggest the bill was viewed as routine appropriations legislation rather than a controversial policy change.
The most notable areas of possible contention are fiscal and administrative rather than ideological: how much funding the board should receive, whether the new attorney position is necessary, and whether allowing up to $500,000 in budget escalation for Pharmacy Benefit Prompt Pay Act enforcement is appropriate. The bill’s detailed restrictions on vacancy funding, salary actions, and headcount management also reflect legislative concern about controlling agency spending. No specific objections are documented in the available materials, but the Senate’s eight no votes suggest some level of disagreement with the appropriation or its conditions.